Hutchmed (China) Limited

Net Asset Value • Jun 24, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5845H

Hutchison China Meditech Limited

24 June 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Notice of Announcement of 2013 Interim Results

London: Monday, 24 June 2013: Chi-Med will be announcing its interim results for the six months ended 30 June 2013 on Tuesday, 30 July 2013.  An analyst presentation will be held at 9:00am on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      +852 2121 8200
Panmure Gordon (UK) Limited Richard Gray Andrew Potts Grishma Patel	Telephone:      +44 20 7886 2500
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      +44 20 7638 9571 Mobile:             +44 7973 611 888 Mobile:             +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORGMGZVLMRGFZG